LEP and metabolic dysfunction-associated steatotic liver disease: Recombinant leptin has also been studied in NASH non-HIV patients as part of a clinical trial (ClinicalTrials.gov Identifier: NCT00596934), but it has not been studied in HIV/NAFLD patients.